Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA business hours over King's Day holiday 25 April 2022NewsHumanCorporateCOVID-19 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022 22 April 2022NewsHumanMedicines Facilitating global access to diabetes treatments for non-EU patients 22 April 2022NewsHumanMedicinesMedicines for use outside the EU EMA starts review of cancer medicine Rubraca 22 April 2022NewsHumanReferrals Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 April 2022 19 April 2022NewsVeterinaryMedicines EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 April 2022NewsHumanCorporate EMA business hours over Easter holiday 12 April 2022NewsHumanCorporateCOVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 April 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 April 2022NewsHumanCOVID-19Vaccines Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 April 2022NewsCorporateFees 1 … 43 44 45 46 47 Page 47 of 380 48 49 50 51 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022 22 April 2022NewsHumanMedicines
Facilitating global access to diabetes treatments for non-EU patients 22 April 2022NewsHumanMedicinesMedicines for use outside the EU
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 April 2022 19 April 2022NewsVeterinaryMedicines
EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 April 2022NewsHumanCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 April 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 April 2022NewsHumanCOVID-19Vaccines
Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 April 2022NewsCorporateFees